Related Experiment Videos

Lipoxin A4 inhibits cholinergic neurotransmission through nitric oxide generation in the rabbit trachea

J Tamaoki1, E Tagaya, I Yamawaki

  • 1First Department of Medicine, Tokyo Women's Medical College, Japan.

Insights

Lipoxin A4 reduces airway smooth muscle contraction by inhibiting acetylcholine release, likely via nitric oxide. Lipoxin B4 showed no effect on this cholinergic neurotransmission.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Respiratory Medicine

Background:

  • Cholinergic neurotransmission regulates airway smooth muscle tone.
  • Lipoxins are inflammatory mediators with diverse biological effects.

Purpose of the Study:

  • To investigate the effects of lipoxin A4 (LXA4) and lipoxin B4 (LXB4) on cholinergic neurotransmission in rabbit tracheal smooth muscle.
  • To elucidate the potential mechanisms underlying LXA4's actions.

Main Methods:

  • Isometric tension recordings in isolated rabbit tracheal segments.
  • Electrical field stimulation (EFS) to assess cholinergic nerve-mediated contractions.
  • Dose-response curves to acetylcholine (ACh).
  • Pharmacological inhibition using NG-nitro-L-arginine methylester (L-NAME) and NG-nitro-D-arginine methylester (D-NAME).

Main Results:

  • LXA4 significantly attenuated contractile responses to EFS, increasing the half-maximal effective stimulus frequency (ES50).
  • LXB4 had no significant effect on EFS-induced contractions.
  • LXA4 did not alter responses to direct acetylcholine application.
  • L-NAME, but not D-NAME, inhibited LXA4's effect on EFS, and this inhibition was reversed by L-arginine.

Conclusions:

  • LXA4 prejunctionally inhibits vagal nerve-mediated airway smooth muscle contraction.
  • This inhibition is likely mediated by reduced acetylcholine release.
  • The mechanism involves the stimulation of nitric oxide (NO) generation.

Related Concept Videos